Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.

Headline

Pregabalin and gabapentin to be reclassified as Class C controlled substances

Comment

I'd like to add to the comment above. When looking at employers asking about medication I can say this has already started. Only last week my company has told me they need a letter from my GP clarifying that I am competent to drive on my medication. How is this an inclusive society? I am being singled out and my own judgement questioned on my driving competency. I have taken pregabalin for years for neuropathic pain. It is one of the drugs that allows me to continue to work and make an economic contribution to society. Yet I feel singled out for having a disability that requires medication. My previous GP informed me a copy of my repeat medication would be sufficient to prove I am being prescribed them so why is this not acceptable for my employer????? Because (excuse my language) it's an ass covering exercise. The industry that proports to be a caring industry should hang their heads in shame. I have never been asked about medication by any other employer. So the shift in attitude has to be driven by changes in classification. I would also point out I was first employed with my disability and medication and no questions were asked then.....

Posted date

9 AUG 2019

Posted time

12:57

Mandatory
Mandatory
Mandatory
Mandatory

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.